Athira Pharma, Inc.
ATHA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $20 | $26 | $48 |
| Short-Term Investments | $4 | $10 | $10 | $3 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $3 | $4 |
| Total Curr. Assets | $27 | $32 | $40 | $55 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $1 |
| Total NC Assets | $3 | $3 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $36 | $44 | $59 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $1 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $4 | $12 |
| Total Curr. Liab. | $3 | $3 | $5 | $13 |
| LT Debt | $0 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $3 | $4 | $6 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$429 | -$422 | -$415 | -$406 |
| AOCI | -$0 | -$0 | -$0 | $0 |
| Other Equity | $456 | $454 | $453 | $451 |
| Total Equity | $27 | $32 | $37 | $45 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $36 | $44 | $59 |
| Net Debt | -$20 | -$19 | -$25 | -$47 |